CHICAGO, December 14, 2022--Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
CHICAGO, November 14, 2022--Exicure reported financial results for the quarter ended September 30, 2022 and provided an update on its business strategy and corporate progress.
CHICAGO, September 26, 2022--Exicure announced plans to restructure the Company and align resources to continue exploring strategic alternatives that maximize stockholder value.